Advertisement

Ohr Pharmaceutical Announces Positive Preclinical Safety Study Results for Squalamine Eye Drop ...

09:24 EDT 11 Jul 2012 | LaMerie

Confirms Ocular and Systemic Safety With Long Term Administration

Original Article: Ohr Pharmaceutical Announces Positive Preclinical Safety Study Results for Squalamine Eye Drop ...

NEXT ARTICLE

More From BioPortfolio on "Ohr Pharmaceutical Announces Positive Preclinical Safety Study Results for Squalamine Eye Drop ..."

Search BioPortfolio: